AG
WX

Ashmore Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Ashmore Group’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-31,838
Closed -$669K – 79
2013
Q2 		$669K Buy
+31,838
New +$622K 0.1% 43

Other funds holding WX

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ashmore Group's WX Position: Q3 2013 in Review

Ashmore Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2013, closing a stake of 31,838 shares — an estimated $669K sold.

Ashmore Group first reported a position in WX in Q2 2013 and held it in 1 quarter. The position peaked at $669K in Q2 2013. 132 funds tracked by Wall St. Rank hold WX as of Q3 2013.

  • Ashmore Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2013 after selling out during the quarter.
  • Ashmore Group sold 31,838 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2013, an estimated $669K.
  • Ashmore Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 1 quarter.
  • Ashmore Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $669K in Q2 2013.
  • 132 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2013.

Based on Ashmore Group's 13F filing for Q3 2013, filed 14 Nov 2013.